Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-006891
Filing Date
2025-01-17
Accepted
2025-01-17 20:37:24
Documents
1
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 5 ownership.html 5  
1 5 ownership.xml 5 3802
  Complete submission text file 0000950170-25-006891.txt   5419
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Issuer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 6207 E. INDIAN BEND RD PARADISE VALLEY AZ 85253
Business Address
GREER R SCOTT (Reporting) CIK: 0001211703 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-24006 | Film No.: 25540143